Grant History

The $5.1M of total grant support we've given to funding research is made possible by the generosity of our sponsors and donors. Real people making an impact on saving children's eyesight.

Grant Amount

$3M
2024
$2.1M

2025

Year
Grant Amount
Month
Amount/ month
Purpose

2025

$2.1M

September
$1M
December
$1.1M

Supported clinical trial application, preparation and funding through the first year of the trial after approval.

2024

$3M

October
$1M
December
$2M

Supported pre-clinical work included dose ranging studies and therapeutic manufacturing.

2024

$3M

October
$1M
December
$2M

Supported pre-clinical work included dose ranging studies and therapeutic manufacturing.

2024

$3M

October
$1M
December
$2M

Supported pre-clinical work included dose ranging studies and therapeutic manufacturing.

News and Articles

Recent News
January 06, 2026
A Race Against Blindness Awards Additional $1.1 Million Grant to Ensure Advancement of AXV-101 into Clinical Trial for Bardet-Biedl Syndrome 1 (BBS1)

Newly added funding closes critical gap and enables planned trial initiation in early 2026

Read More
A Race Against Blindness Awards Additional $1.1 Million Grant to Ensure Advancement of AXV-101 into Clinical Trial for Bardet-Biedl Syndrome 1 (BBS1)

Latest Posts

March 13, 2024
Bardet-Biedl Syndrome

Bardet-Biedl Syndrome (BBS) is a rare genetic disorder that affects multiple body systems, causing vision problems, obesity, kidney issues, extra fingers or toes, and intellectual disabilities. It is inherited in an autosomal recessive pattern and affects about 1 in 100,000 to 160,000 people worldwide. Diagnosis involves clinical evaluation and genetic testing. Current research focuses on understanding its genetic causes, studying cilia function, and developing treatments to manage its symptoms.

Read More